Category: Biotech
Cognetivity Neurosciences Announces Commercial Dep...
Posted by Editorial Staff | Mar 2, 2021 | Biotech | 0
Walker Announces Exploration Program Update From t...
Posted by Abigale Lormen | Feb 10, 2021 | Biotech | 0
‘Blockbuster’ Migraine Therapy: Incent...
Posted by Abigale Lormen | Sep 22, 2019 | Biotech | 0
Scientists Are One Step Closer to Treating Melanom...
Posted by Abigale Lormen | Sep 7, 2019 | Biotech | 0
NY Attorney General Probes Eli Lilly Over High Ins...
Posted by Abigale Lormen | Aug 3, 2019 | Biotech | 0
Former UK Health Minister Lord O’Shaughnessy Joins Advisory Board at Cognetivity Neurosciences
by Abigale Lormen | Apr 12, 2021 | Biotech | 0
Lord O’Shaughnessy brings a wealth of experience in healthcare policy, government and life...
Read MoreCognetivity Neurosciences Announces Commercial Deployment of OptiMind Wellness App with Market-Leading Telehealth Company
by Editorial Staff | Mar 2, 2021 | Biotech | 0
Cognetivity’s unique cognition-monitoring technology to be deployed to measure positive...
Read MoreCognetivity Neurosciences Selected to Join UK Innovation Agency Programme for UK’s Most Outstanding Scaling Businesses
by Editorial Staff | Feb 11, 2021 | Biotech | 0
Cognetivity joins select group of UK scaleups deemed capable of achieving at least 50% annual growth VANCOUVER, BC, Feb. 11, 2021 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or...
Read MoreWalker Announces Exploration Program Update From the Lapon Gold Project
by Abigale Lormen | Feb 10, 2021 | Biotech | 0
VANCOUVER, British Columbia, Feb. 10, 2021 (GLOBE NEWSWIRE) — Walker River Resources...
Read MoreCognetivity Neurosciences expands ongoing UK government-funded study to include Covid-safe remote cognitive assessment
Cognetivity’s iPad-based Integrated Cognitive Assessment (ICA) well suited to remote use as global demand for telehealth continues to surge VANCOUVER, BC, Jan. 12, 2021 /CNW/ – Cognetivity Neurosciences...
Read More‘Blockbuster’ Migraine Therapy: Incentive for Lundbeck’s $2B Alder Acquisition
by Abigale Lormen | Sep 22, 2019 | Biotech | 0
Denmark’s international pharmaceutical company, Lundbeck has acquired Alder in a bid to...
Read MoreScientists Are One Step Closer to Treating Melanoma
by Abigale Lormen | Sep 7, 2019 | Biotech | 0
Last Sunday, researchers from the Massachusetts Institute of Technology presented their study...
Read MoreNY Attorney General Probes Eli Lilly Over High Insulin Prices
by Abigale Lormen | Aug 3, 2019 | Biotech | 0
Eli Lilly has been served a subpoena from the Office of the Attorney General in New York because...
Read MoreGilead Beat Street Forecasts Due to Increasing Demand for HIV Drug
by Abigale Lormen | Aug 1, 2019 | Biotech | 0
Gilead Sciences Inc. (GILD.O) beat Wall Street forecasts for its profit and revenue for the second...
Read MoreCognetivity Neurosciences’ CMO to Present at Alzheimer’s Association International Conference (AAIC) 2019
by Editorial Staff | Jul 16, 2019 | Biotech, Markets, Tech | 0
AAIC is the Largest and Most Influential International Meeting Dedicated to Advancing Dementia Science Cognetivity’s Chief Medical Officer to Present Latest Company Research and Platform Capability Focused on Early...
Read MoreEarly Detection of Dementia by Observing the Eyes
by Abigale Lormen | Jul 11, 2019 | Biotech | 0
Currently, many people around the globe develop dementia as they grow older. For the longest time,...
Read MoreMicrosoft Prepares to Make Biggest Gamble of 2019
by Abigale Lormen | Jul 10, 2019 | Biotech | 0
Microfost’s initial plans to invest in health-care company Adaptive Biotechnologies two...
Read More
Recent Posts
-
VERSUS SYSTEMS TO ALLOW PRIZING IN INDIAApr 13, 2021 | Press Release
-
-
-
-